Definitive Contract 75N92022C00001
Ended Awarded Last action
- Contract number
- 75N92022C00001
- Awardee
-
Tangen Biosciences, Inc. UEI K3D1V93LH4F8
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,684,000
Award facts
- Contract value 100% obligated
- $2,684,000.00 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Funding agency
- National Institute of Biomedical Imaging and Bioenginering National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Branford, CT 06405, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Change Order | -$353,000 | |
| Other Administrative Action | $0 | |
| Original award | $3,037,000 |
About this award
The Department of Health and Human Services' National Institutes of Health National Institute of Biomedical Imaging and Bioengineering awarded a $2.68 million firm fixed price definitive contract to Tangen Biosciences, Inc. of Branford, Connecticut. The contract, EO14042 TECH PROJECT # 6399, is for Tangen Biosciences to scale up their Tangen assay and production capabilities from November 2021 through June 2023. No set aside designation or major subcontractors were indicated. The National Institute of Biomedical Imaging and Bioengineering frequently supports contracts advancing biomedical technologies, so this award is likely intended to help Tangen Biosciences further develop and produce their assay for biomedical applications.
Quick answers
Who was awarded contract 75N92022C00001?
75N92022C00001 was awarded to Tangen Biosciences, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on November 23, 2021.
How much is contract 75N92022C00001 worth?
The government has obligated $2,684,000 on 75N92022C00001.
Which agency awarded contract 75N92022C00001?
National Heart Lung and Blood Institute (National Institutes of Health) awarded 75N92022C00001, with funding from National Institute of Biomedical Imaging and Bioenginering (National Institutes of Health).
Was contract 75N92022C00001 competed?
The extent of competition for 75N92022C00001 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award